17-02-15-Receipt of R&D Tax Incentive Refund.pdfSUMMARY

2015 ASX Announcements

  

17 February, 2015     

 

                                   

28 January, 2015

PI-88 Clinical Trial Update.pdf

 

 

2014 ASX Announcements

20 November 2014

Appendix 3Y Change in Director's Interest Notice - Dr Hongjen Chang































































































































































































































































































































































































































































































































 

20 November 2014

Appendix 3Y Change in Director's Interest Notice - Heng Tang































































































































































































































































































































































































































































































































 

20 November 2014

Appendix 3Y Change of Director's Interest Notice - Jitto Arulampalam































































































































































































































































































































































































































































































































 

20 November 2014

Issue of Unlisted Options to Contractors































































































































































































































































































































































































































































































































 

20 November 2014

Issue of Unlisted Options to Directors































































































































































































































































































































































































































































































































 

17 November 2014

Notice of Allowance of Canada Patent for PG545 and related compounds































































































































































































































































































































































































































































































































 

10 November 2014

Results of 2014 Annual General Meeting































































































































































































































































































































































































































































































































 

10 November 2014

2014 Annual General Meeting Address































































































































































































































































































































































































































































































































 

7 October 2014

2014 Annual General Meeting Documentation































































































































































































































































































































































































































































































































 

22 September 2014

PG545 Phase 1 Clinical Trial Successfully Completes First Patient Cohort































































































































































































































































































































































































































































































































 

26 August 2014

Preliminary Final Report Year Ended 30 June 2014































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































30 July 2014

Update to Interim Phase III Results for PI-88































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































29 July 2014

Interim Phase III Results for PI-88

 

21 July 2014

European Patent Office Intention to Grant Sulfated Oligosaccharide Derivatives Patent































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































9 July 2014

Medigen Schedules PI-88 Interim Patient Analysis July 2014.pdf































































































































































































































































































































































































































































































































 

28 May 2014

Change of Head Office Address































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































19 May 2014

Change of Director's Interest Notice 































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































15 May 2014

PG545 Phase 1 Clinical Trial Successfully Completes First Patient Cohort































































































































































































































































































































































































































































































































 

14 May 2014

Changes to Management and Corporate Office Address































































































































































































































































































































































































































































































































 

9 May 2014

Medigen Expects PI-88 Interim Patient Data in May 2014































































































































































































































































































































































































































































































































 

29 April 2014

Medigen Biotechnology Engages Pharmasynth to Manufacture PI-88 Registration Batches































































































































































































































































































































































































































































































































 

28 April 2014

Notice of Allowance of US patent for PG545 & related compounds































































































































































































































































































































































































































































































































 

9 April 2014

PG545 Data Presented at AACR Conference































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































02 April 2014

Issue of Unlisted Options under Employee Share Option Plan 2 April 2014

 

13 March 2014

Appendix 3Y Change of Director's Interest Notice































































































































































































































































































































































































































































































































 

28 February 2014

Appendix 4D - Interim Financial Report































































































































































































































































































































































































































































































































 

13 February 2014

PG545 Data Presented at Lorne Cancer Conference































































































































































































































































































































































































































































































































 

31 January 2014

Receipt of R&D Tax Incentive Refund

 

2013 ASX Announcements

30 December 2013

PATRON Trial Completes Patient Recruitment































































































































































































































































































































































































































































































































 

20 December 2013

Lodgement of Change in Director's Interest Notice































































































































































































































































































































































































































































































































 

17 December 2013

R&D Tax Incentive 17 Dec 2013































































































































































































































































































































































































































































































































 

17 December 2013

2013 Form 20-F A Filed with US SEC































































































































































































































































































































































































































































































































 

6 December 2013

Change of Director's Interest Notice































































































































































































































































































































































































































































































































 

3 December 2013

Beta Therapeutics Assignment Agreement































































































































































































































































































































































































































































































































 

2 December 2013

Initial Director's Interest Notice Appendix 3X































































































































































































































































































































































































































































































































 

29 November 2013

Final Director's Interest Notice Appendix 3Z































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































29 November 2013

2013 Annual General Meeting Address































































































































































































































































































































































































































































































































 

29 November 2013

Appointment of Director and Chair































































































































































































































































































































































































































































































































 

28 November 2013

Results of 2013 Annual General Meeting

 

26 November 2013

Change to Board of Directors































































































































































































































































































































































































































































































































 

1st November 2013

2013 Form 20-F Filed with the US SEC.pdf































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































30th October 2013

PG545 Phase 1 Cancer Trial Update































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































25th October 2013

2013 Annual General Meeting Documentation































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































22nd October 2013

Change to Acting Managing Director's Terms of Employment































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































8th October 2013

Issue of Unlisted Options under Employee Share Option Plan































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































28th August 2013

Preliminary Final Report Year Ended 30 June 2013































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12th July 2013

PI-88 Phase III Update































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12th July 2013

Appendix 3X Initial Director's Interest Notice































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12th July 2013

Appendix 3Z Final Director's Interest Notice































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12th July 2013

Board & Senior Management Changes































































































































































































































































































































































































































































































































 

9th July 2013

PG545 Published in Molecular Cancer Therapeutics































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5th June 2013

Form 605 - Notice of Ceasing to be a Substantial Holder































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































30th May 2013

Form 605 - Notice of Ceasing to be a Substantial Holder































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































29th May 2013

Form 604 - Notice of Change of Interest of Substantial Holder

 

29th May 2013

Form 603 - Notice of Initial Substantial Holder































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































29th May 2013

Notice Under Section 708A(5)(e)































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































27th May 2013

Completion of Share Placement































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































27th May 2013

Change in Substantial Holding

 

22nd May 2013

Non-Renounceable Rights Issue Share Allotment































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































22nd May 2013

Notice Under Section 708A(5)(e)

 

22nd May 2013

Appendix 3Y Change of Director's Interest Notice































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































22nd May 2013

Appendix 3Y Change of Director's Interest Notice 22May13

 

21st May 2013

Notification of Subscriptions































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1st May 2013

Dispatch of Non-Renounceable Rights Issue Offer Document

 

18th April 2013

Notice to Eligible Shareholders 18 Apr 2013































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































18th April 2013

Notice to Ineligible Shareholders































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































17th April 2013

Rights Issue - Notice Under Section 708AA(2)(f)































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































17th April 2013

Non-Renounceable Rights Issue Offer - Letter to Option Holders































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































17th April 2013

Offer Document































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































16th April 2013

Non Renounceable Pro Rata Rights Issue































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































16th April 2013

Appendix 3B































































































































































































































































































































































































































































































































 

26th March 2013

Appendix 3Y































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































12th March 2013

Change of Director's Interest Notice































































































































































































































































































































































































































































































































 

1st March 2013

Progen Pharmaceuticals signs License with Medigen Biotech Corp































































































































































































































































































































































































































































































































 

31st January 2013

Receipt of R&D Tax Incentive Refund































































































































































































































































































































































































































































































































 

31st January 2013

Qld Storm - Operations Unaffected































































































































































































































































































































































































































































































































 

11th January 2013

R&D Tax Incentive Refund































































































































































































































































































































































































































































































































2012 ASX Announcements

 

31st December 2012

Appendix 4D Interim Financial Report































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































28th December 2012

Progen Pharmaceuticals Ltd signs Binding License Term Sheet































































































































































































































































































































































































































































































































 

6th December 2012

Appendix 3Yf































































































































































































































































































































































































































































































































 

4th December 2012

2012 Form 20-F Filed with the US SEC































































































































































































































































































































































































































































































































 

25th September 2012

Appendix 3Y 25 Sept 12